Search
Patexia Community

Innovation, Technology, and IP News

Patexia Insight 161: Top CAFC Law Firms of 2022

In late October, we released our second annual CAFC Intelligence Report. The report provided high-level statistics and insights and evaluated the stakeholders participating in the...

"They've Helped Themselves to My Artwork..." Banksy Accuses GUESS

  “Attention All Shoplifters…” Another guerrilla marketing strategy or unintentional (intentional) copyright infringement? This fall/winter 2022...

Get to Know This Year's Women Leaders in Tech Law

The Recorder honored the women lawyers handling game-changing, law-shaping, market moving work in and around the tech sector as part of the California Legal Awards on Nov. 3. Meet...

California Police Play Copyrighted Disney Tunes to Avoid YouTube Publishing

  Copyright intends to protect the rights of creators, but here is an interesting use that you probably haven't thought about. In recent years, the recording of police...

Feed tagged as "pharmaceuticals":
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed... Read More »
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in ... Read More »
MYLAN PHARMACEUTICALS INC. v. MERCK SHARP & DOHME CORP. Before Lourie, Reyna and Stoll.  Appeal from the Patent Trial and Appeal... Read More »
Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused on... Read More »
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More »
In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by providing... Read More »
The Federal Circuit has affirmed that Eagle Pharmaceuticals, Inc. did not infringe Par Pharmaceutical, Inc. patents, easing... Read More »
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »
PAR PHARMACEUTICAL, INC. V. EAGLE PHARMACETICALS, INC. Before Moore, Prost, and Hughes. Appeal from the United States District Court for... Read More »
This morning we released our third annual ANDA Litigation Intelligence Report. The report covers high-level statistics related to Hatch-Waxman... Read More »
  The FDA evaluates the generic versions of a drug and approves them only if studies show that it is bioequivalent with the... Read More »
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that... Read More »
Two weeks ago, Curevac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech over patent infringement alleging... Read More »
  Small molecule drugs have been the norm for much of medicine’s history. Only in the past decade has there been a rise ... Read More »
On June 16, 2022, the World Trade Organization (WTO) agreed to a partial waiver of intellectual property rights related to... Read More »
Last week, a bipartisan group of six U.S. senators sent a letter to USPTO asking to take measures in order to combat patent thickets... Read More »
NOVARTIS PHARMACEUTICALS CORP. V. HEC PHARM CO., LTD. Before Moore, Hughes, and Linn (dissenting).  Appeal from the United States... Read More »
The pandemic we just went through was one of the examples of how important is the patent system in strengthening the public health... Read More »
ResApp Health recently announced its planned sale to Pfizer Australia, a wholly owned subsidiary of Pfizer Inc. ... Read More »
Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound... Read More »
Show more Newsfeed posts
Menu